Prenatal vitamin D for schizophrenia

The genetic and environmental factors behind schizophrenia are poorly understood, but research is increasingly finding links between maternal vitamin D status and the risk...

Pain pointers: How to prepare your pharmacy for codeine change

Preparing now for the up‑scheduling of codeine‑containing medicines to prescription-only will mean pharmacists are in a better position to inform and educate their customers....

A new national approach to pain management

The new National Strategic Action Plan for Pain Management offers plenty of opportunities for pharmacists to work to their full scope of practice. The Action...

Amitriptyline for irritable bowel syndrome

Ordinarily used to treat other conditions, this trycylic antidepressant performed well in a recent trial on people with IBS. Irritable bowel syndrome (IBS) is estimated...

Realising pharmacists’ full potential

We are working to achieve the 11 key actions in Pharmacists in 2023 to unlock opportunities for pharmacists as the custodians of medicine safety. I was...

Depression and complementary medicines

Around one in 16 Australians will suffer from depression at some time during their life.1,2 What evidence is there that complementary medicines such as S-Adenosyl-L-methionine...